Market By Device Type, Therapeutic Area, Display Technologies, End-user And Geography | Forecast 2019-2027
According to Triton, the global biopsy device market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 6.81%. The market was assessed to be worth $1826.962 million in the year 2018 and is predicted to generate a revenue of approximately $3302.211 million by the year 2027.
The cancer prevalence is defined as the number of people who were diagnosed with cancer in their lifetime. Prevalence is described as the repetition of the occurrence of cancer and the life expectancy of the patient after diagnosis. The number of new cases is believed to rise by 70% in the next two decades. According to WHO projects, cancer is one of the leading causes of mortality worldwide, with around 14 million new cases and 8.2 million cancer-related deaths registered in 2012.
The biopsy device market growth is directly dependent on the number of incidents of cancer, that is growing at a rapid pace, resulting in the expansion of the patient base for these devices. With the help of early diagnosis and biopsy, a large number of deaths that occur due to cancer worldwide can be prevented by enabling the creation of a suitable treatment plan. The rise in the awareness and the growth of the geriatric population are the other main factors that are primarily responsible for fueling the biopsy device market growth globally.
Biopsy devices are gaining importance in the market as a feasible substitute for conventional screening methods for chronic conditions like cancer. The biopsy device market is expected to experience considerable growth over the forecast period, mainly steered by the rising prevalence of cancer, old age and rising demand for minimally invasive procedures. The growing awareness levels among the patients and the advancement in biopsy techniques are also expected to boost the growth of this market in the near future.
Within this report on biopsy device market, the key insights regarding the industry, the market attractiveness matrix, regulations outlook for biopsy devices in the United States and European Union, reimbursement outlook in the United States, patents outlook and Porter's five force analysis strategies are discussed in detail.
The rising prevalence of chronic diseases, increasing public knowledge about the mode of disease transmission and the growing number of diagnostics centers worldwide are the top drivers surging the market growth across the globe. The industry is facing market restraints such as low availability skilled professionals and reimbursement issues which are responsible for obstructing the industry growth.
The key opportunities like growing incidences of liver disease can be leveraged by the industry to achieve the projected growth over the forecasting years. However, limited technical skills and high costs of biopsy techniques are the challenges faced by the industry at this moment.
The top geographies studied in the global biopsy device market are:
• North America: United States and Canada
• Europe: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific
• Latin America: Brazil, Mexico and Rest of Latin America
• Middle East & Africa United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East & Africa
The biopsy device market, in this report, is segmented on the basis of device type, therapeutic area, display technologies and end-users.
• By device type:
O Breast biopsy
• Vacuum-assisted core biopsy (VAB)
• Core needle biopsy (CNB)
• Fine needle biopsy (FNB)
O Gastrointestinal (GI) Biopsy
O Soft tissue biopsy needles
O Bronchial biopsy device
O Gynecological biopsy device
O Robotic guidance system
O Other devices
• By therapeutic area:
O Breast biopsy
O GI biopsy
O Prostate biopsy
O Liver biopsy
O Kidney biopsy
O Gynecological biopsy
O Other therapeutic areas
• By display technologies:
O MRI-guided biopsy
O Stereo tactics-guided biopsy
O Ultrasound-guided biopsy
O CT-guided biopsy
O Other display technologies
• By end user:
O Diagnosis center
O Hospitals
• Specialist
• General
The key players in the biopsy device market are Becton, Dickinson, Fischer Medical Technologies LLC, B. Braun Melsungen AG, Cardinal Health, Inc., Cintec Medical Ltd., C. R. Bard, Inc., Boston Scientific Corporation, QIAGEN N.V., Cook Group, Inc., Argon Medical Devices, Inc., I.M.S. Internazionale Medico Scientifica SRL, Planmeca Oy and Ad-Tech Medical Instrument Corp.
The strategic analysis for each of these companies has been covered in the biopsy device market report. The company market share helps to dive in the information about the key market players in this industry and their hold on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
BIOPSY DEVICE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCE OUTLOOK
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF RIVALRY
2.3. MARKET
ATTRACTIVENESS MATRIX
2.4. VENDOR
SCORECARD
2.5. KEY
INSIGHTS
2.6. REGULATIONS
OUTLOOK
2.6.1. REGULATION
OF BIOPSY DEVICES IN THE UNITED STATES
2.6.2. REGULATION
OF BIOPSY DEVICES IN THE EUROPEAN UNION
2.7. REIMBURSEMENT
OUTLOOK IN THE UNITED STATES
2.8. PATENTS
OUTLOOK
2.9. MARKET
DRIVERS
2.9.1. PREVALENCE
OF CHRONIC DISEASES ON THE RISE
2.9.2. GROWING
PUBLIC KNOWLEDGE OF DISEASE TRANSMISSION
2.9.3. INCREASING
DIAGNOSTIC CENTERS
2.10.
RESTRAINTS
2.10.1.
DEARTH OF SKILLED
PROFESSIONALS
2.10.2.
REIMBURSEMENT ISSUES
2.11.
OPPORTUNITIES
2.11.1.
INCREASING INCIDENCE OF LIVER
DISEASES
2.12.
MARKET CHALLENGES
2.12.1.
TECHNICAL SKILLS ARE LIMITED
2.12.2.
COST OF BIOPSY TECHNIQUES IS
HIGH
3. BIOPSY
DEVICE MARKET OUTLOOK - BY DEVICE TYPE
3.1. BREAST
BIOPSY
3.1.1. VACUUM-ASSISTED
CORE BIOPSY (VAB)
3.1.2. CORE
NEEDLE BIOPSY (CNB)
3.1.3. FINE
NEEDLE BIOPSY
3.2. GASTROINTESTINAL
(GI) BIOPSY
3.3. SOFT
TISSUE BIOPSY NEEDLES
3.4. BRONCHIAL BIOPSY
3.5. GYNECOLOGICAL BIOPSY DEVICE
3.6. ROBOTIC
GUIDANCE SYSTEM
3.7. OTHER
DEVICES
4. BIOPSY
DEVICE MARKET OUTLOOK - BY THERAPEUTIC
AREA
4.1. BREAST
BIOPSY
4.2. GI
BIOPSY
4.3. PROSTATE
BIOPSY
4.4. LIVER
BIOPSY
4.5. LUNG
BIOPSY
4.6. KIDNEY
BIOPSY
4.7. GYNECOLOGICAL BIOPSY
4.8. OTHER
THERAPEUTIC AREA
5. BIOPSY
DEVICE MARKET OUTLOOK - BY DISPLAY TECHNOLOGIES
5.1. MRI-GUIDED
BIOPSY
5.2. STEREOTACTIC-GUIDED BIOPSY
5.3. ULTRASOUND-GUIDED
BIOPSY
5.4. CT-GUIDED
BIOPSY
5.5. OTHER
DISPLAY TECHNOLOGIES
6. BIOPSY
DEVICE MARKET OUTLOOK - BY END-USER
6.1. DIAGNOSIS
CENTER
6.2. HOSPITALS
6.2.1. SPECIALIST
6.2.2. GENERAL
7. BIOPSY
DEVICE MARKET - REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY DEVICE TYPE
7.1.2. MARKET
BY THERAPEUTIC AREAS
7.1.3. MARKET
BY DISPLAY TECHNOLOGIES
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY DEVICE TYPE
7.2.2. MARKET
BY THERAPEUTIC AREAS
7.2.3. MARKET
BY DISPLAY TECHNOLOGIES
7.2.4. MARKET
BY END-USER
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. UNITED
KINGDOM
7.2.5.2. FRANCE
7.2.5.3. GERMANY
7.2.5.4. ITALY
7.2.5.5. SPAIN
7.2.5.6. RUSSIA
7.2.5.7. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY DEVICE TYPE
7.3.2. MARKET
BY THERAPEUTIC AREAS
7.3.3. MARKET
BY DISPLAY TECHNOLOGIES
7.3.4. MARKET
BY END-USER
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. JAPAN
7.3.5.2. CHINA
7.3.5.3. INDIA
7.3.5.4. SOUTH
KOREA
7.3.5.5. AUSTRALIA
& NEW ZEALAND
7.3.5.6. ASEAN
COUNTRIES
7.3.5.7. REST
OF APAC
7.4. MIDDLE
EAST AND AFRICA
7.4.1. MARKET
BY DEVICE TYPE
7.4.2. MARKET
BY THERAPEUTIC AREAS
7.4.3. MARKET
BY DISPLAY TECHNOLOGIES
7.4.4. MARKET
BY END-USER
7.4.5. COUNTRY
ANALYSIS
7.4.5.1.1.
SAUDI ARABIA
7.4.5.1.2.
TURKEY
7.4.5.1.3.
UNITED ARAB EMIRATES
7.4.5.1.4.
SOUTH AFRICA
7.4.5.1.5.
REST OF MIDDLE EAST AND AFRICA
7.5. LATIN
AMERICA
7.5.1. MARKET
BY DEVICE TYPE
7.5.2. MARKET
BY THERAPEUTIC AREAS
7.5.3. MARKET
BY DISPLAY TECHNOLOGIES
7.5.4. MARKET
BY END-USER
7.5.5. COUNTRY
ANALYSIS
7.5.5.1.1.
BRAZIL
7.5.5.1.2.
MEXICO
7.5.5.1.3.
REST OF LATIN AMERICA
8. COMPANY
PROFILES
8.1. AD-TECH
MEDICAL INSTRUMENT CORP.
8.2. ARGON
MEDICAL DEVICES, INC.
8.3. B.
BRAUN MELSUNGEN AG
8.4. BECTON,
DICKINSON
8.5. BOSTON
SCIENTIFIC CORPORATION
8.6. CARDINAL
HEALTH, INC.
8.7. C.
R. BARD, INC.
8.8. CINTEC
MEDICAL, LTD.
8.9. COOK
GROUP, INC.
8.10.
FISCHER MEDICAL TECHNOLOGIES
LLC
8.11.
I.M.S. INTERNAZIONALE MEDICO
SCIENTIFICA SRL
8.12.
PLANMECA OY
8.13.
QIAGEN N.V.
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1 GLOBAL BIOPSY DEVICE MARKET BY REGION
2019-2027 ($ MILLION)
TABLE 2 IMPLEMENTATION OF BREAST CANCER
SCREENING PLATFORMS IN EU BY COUNTRY
TABLE 3 COST OF BIOPSY FOR UNINSURED PEOPLE IN
THE US 2016
TABLE 4 GLOBAL BIOPSY DEVICE MARKET BY DEVICE
TYPE 2019-2027 ($ MILLION)
TABLE 5 GLOBAL BIOPSY DEVICE MARKET IN BREAST
BIOPSY DEVICE BY TYPES 2019-2027 ($ MILLION)
TABLE 6 TYPES OF BREAST BIOPSY AND MAMMOGRAPHY
EQUIPMENT
TABLE 7 TYPES OF BIOPSY CURETTES
TABLE 8 GLOBAL BIOPSY DEVICE MARKET BY
THERAPEUTIC AREA 2019-2027 ($ MILLION)
TABLE 9 GLOBAL BIOPSY DEVICE MARKET BY DISPLAY
TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 10 GLOBAL BIOPSY DEVICE MARKET BY END-USER 2019-2027
($ MILLION)
TABLE 11 COMMON AREAS OF BIOPSY
TABLE 12 GLOBAL BIOPSY DEVICE MARKET IN HOSPITAL 2019-2027
($ MILLION)
TABLE 13 NORTH AMERICA BIOPSY DEVICE MARKET BY
DEVICE TYPE 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA BIOPSY DEVICE MARKET BY
THERAPEUTIC AREAS 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA BIOPSY DEVICE MARKET BY
DISPLAY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA BIOPSY DEVICE MARKET BY END-USER
2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA BIOPSY DEVICE MARKET BY
COUNTRIES 2019-2027 ($ MILLION)
TABLE 18 EUROPE BIOPSY DEVICE MARKET BY DEVICE TYPE
2019-2027 ($ MILLION)
TABLE 19 EUROPE BIOPSY DEVICE MARKET BY THERAPEUTIC
AREAS 2019-2027 ($ MILLION)
TABLE 20 EUROPE BIOPSY DEVICE MARKET BY DISPLAY
TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 21 EUROPE BIOPSY DEVICE MARKET BY END-USER 2019-2027
($ MILLION)
TABLE 22 EUROPE BIOPSY DEVICE MARKET BY COUNTRIES
2019-2027 ($ MILLION)
TABLE 23 ASIA-PACIFIC BIOPSY DEVICE MARKET BY
DEVICE TYPE 2019-2027 ($ MILLION)
TABLE 24 ASIA-PACIFIC BIOPSY DEVICE MARKET BY
THERAPEUTIC AREAS 2019-2027 ($ MILLION)
TABLE 25 ASIA-PACIFIC BIOPSY DEVICE MARKET BY
DISPLAY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 26 ASIA-PACIFIC BIOPSY DEVICE MARKET BY END-USER
2019-2027 ($ MILLION)
TABLE 27 ASIA-PACIFIC BIOPSY DEVICE MARKET BY
COUNTRIES 2019-2027 ($ MILLION)
TABLE 28 MIDDLE EAST AND AFRICA BIOPSY DEVICE
MARKET BY DEVICE TYPE 2019-2027 ($ MILLION)
TABLE 29 MIDDLE EAST AND AFRICA BIOPSY DEVICE
MARKET BY THERAPEUTIC AREAS 2019-2027 ($ MILLION)
TABLE 30 MIDDLE EAST AND AFRICA BIOPSY DEVICE
MARKET BY DISPLAY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 31 MIDDLE EAST AND AFRICA BIOPSY DEVICE
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 33 MIDDLE EAST AND AFRICA BIOPSY DEVICE
MARKET BY COUNTRIES 2019-2027 ($ MILLION)
TABLE 28 LATIN AMERICA BIOPSY DEVICE MARKET BY
DEVICE TYPE 2019-2027 ($ MILLION)
TABLE 29 LATIN AMERICA BIOPSY DEVICE MARKET BY
THERAPEUTIC AREAS 2019-2027 ($ MILLION)
TABLE 30 LATIN AMERICA BIOPSY DEVICE MARKET BY
DISPLAY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 31 LATIN AMERICA BIOPSY DEVICE MARKET BY END-USER
2019-2027 ($ MILLION)
TABLE 34 LATIN AMERICA BIOPSY DEVICE MARKET BY
COUNTRIES 2019-2027 ($ MILLION)
FIGURE 1 SHARES OF THE U.S. PATENT HOLDER (%)
FIGURE 2 SHARES OF THE EUROPEAN PATENT HOLDER (%)
FIGURE 3 SHARES OF THE JAPANESE PATENT HOLDER (%)
FIGURE 4 GLOBAL BIOPSY DEVICE MARKET IN BREAST
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL BREAST BIOPSY DEVICE MARKET IN
VACUUM ASSISTED CORE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 6 GLOBAL BREAST BIOPSY DEVICE MARKET IN CORE
NEEDLE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL BREAST BIOPSY DEVICE MARKET IN FINE
NEEDLE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL BIOPSY DEVICE MARKET IN GI BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL BIOPSY DEVICE MARKET IN SOFT TISSUE
BIOPSY NEEDLES MARKET 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL BIOPSY DEVICE MARKET IN BRONCHIAL
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL BIOPSY DEVICE MARKET IN GYNECOLOGICAL
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL BIOPSY DEVICE MARKET IN ROBOTIC
GUIDANCE SYSTEM 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL BIOPSY DEVICE MARKET IN OTHER BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL BIOPSY DEVICE MARKET IN BREAST BIOPSY
THERAPEUTIC AREA 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL BIOPSY DEVICE MARKET IN GI BIOPSY
2019-2027 ($ MILLION)
FIGURE 16 GLOBAL BIOPSY DEVICE MARKET IN PROSTATE
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL BIOPSY DEVICE MARKET IN LIVER BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL BIOPSY DEVICE MARKET IN LUNG BIOPSY
DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL BIOPSY DEVICE MARKET IN KIDNEY BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL BIOPSY DEVICE MARKET IN GYNECOLOGICAL
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 21 GLOBAL BIOPSY DEVICE MARKET IN OTHER
THERAPEUTIC AREA 2019-2027 ($ MILLION)
FIGURE 22 GLOBAL BIOPSY DEVICE MARKET IN MRI GUIDED
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL BIOPSY DEVICE MARKET IN STEREOTACTIC
BREAST BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 24 GLOBAL BIOPSY DEVICE MARKET IN ULTRASOUND
GUIDED BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 25 GLOBAL BIOPSY DEVICE MARKET IN CT GUIDED
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 26 GLOBAL BIOPSY DEVICE MARKET IN OTHER DISPLAY
TECHNOLOGIES BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 27 GLOBAL BIOPSY DEVICE MARKET IN DIAGNOSIS
CENTER 2019-2027 ($ MILLION)
FIGURE 28 GLOBAL BIOPSY DEVICE MARKET IN HOSPITAL
2019-2027 ($ MILLION)
FIGURE 29 GLOBAL HOSPITAL MARKET IN SPECIALIST HOSPITAL
2019-2027 ($ MILLION)
FIGURE 30 GLOBAL HOSPITAL MARKET IN GENERAL HOSPITAL
2019-2027 ($ MILLION)
FIGURE 31 NORTH AMERICA BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 32 UNITED STATES BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 33 CANADA BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 34 EUROPE BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 35 UNITED KINGDOM BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 36 FRANCE BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 37 GERMANY BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 38 ITALY BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 39 SPAIN BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 40 RUSSIA BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 41 REST OF EUROPE BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 42 JAPAN BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 43 CHINA BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 44 INDIA BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 45 SOUTH KOREA BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 46 AUSTRALIA & NEW ZEALAND BIOPSY DEVICE
MARKET 2019-2027 ($ MILLION)
FIGURE 47 ASEAN COUNTRIES BIOPSY DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 48 REST OF APAC BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 49 SAUDI ARABIA BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 50 TURKEY BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 51 UNITED ARAB EMIRATES BIOPSY DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 52 SOUTH AFRICA BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 53 REST OF MIDDLE EAST AND AFRIC BIOPSY DEVICE
MARKET 2019-2027 ($ MILLION)
FIGURE 54 BRAZIL BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 55 MEXICO BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 56 REST OF LATIN AMERICA BIOPSY DEVICE MARKET
2019-2027 ($ MILLION)